Imaging of the Antidepressant Drug Response Using SPECT and PET

作者: Ralf P. Clauss , Max Zöttl , Mike Sathekge

DOI: 10.1007/978-3-642-40384-2_12

关键词:

摘要: SPECT and PET imaging has played an important role in the evaluation of pharmaceutical interventions mood disorders such as depression.

参考文章(115)
Deborah Y. Liggan, Jerald Kay, Some neurobiological aspects of psychotherapy. A review. The journal of psychotherapy practice and research. ,vol. 8, pp. 103- 114 ,(1999)
Robert B Zipursky, Jeffrey H Meyer, N Paul Verhoeff, PET and SPECT imaging in psychiatric disorders. The Canadian Journal of Psychiatry. ,vol. 52, pp. 146- 157 ,(2007) , 10.1177/070674370705200303
David J. Nutt, Relationship of neurotransmitters to the symptoms of major depressive disorder. The Journal of Clinical Psychiatry. ,vol. 69, pp. 4- 7 ,(2008)
Michael Gilhooley, Mark Agius, Abigail Davis, USING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IN THE TREATMENT OF DEPRESSION Psychiatria Danubina. ,(2010)
Coppen Aj, Biochemical aspects of depression International psychiatry clinics. ,vol. 6, pp. 53- 81 ,(1969)
L Oehme, W G Franke, B Beuthien-Baumann, U Pietrzyk, O Bach, V A Holthoff, J Pinkert, Changes in regional cerebral perfusion in depression.SPECT monitoring of response to treatment Nervenarzt. ,vol. 70, pp. 620- 626 ,(1999) , 10.1007/S001150050487
M. R. Lemke, Dopaminagonisten als Antidepressiva Nervenarzt. ,vol. 78, pp. 31- 38 ,(2007) , 10.1007/S00115-006-2104-0
V. P. Whittaker, The Synaptic Vesicle Springer, Boston, MA. pp. 41- 69 ,(1984) , 10.1007/978-1-4684-4586-2_2